SpinaFX Medical Inc., a Toronto, Canada-based provider of a minimally invasive image-guided spinal care solutions, closed the Series B funding, raising a last tranche of CAD $5.3M.
Backers were not disclosed.
The company intends to use the funds to expand operations and its development efforts.
Founded by Dr. Kieran Murphy and led by CEO Jeff Cambra, SpinaFX is a medical device company working on bringing innovative, minimally invasive image-guided treatments to patients with back pain due to contained herniated discs. The company is addressing this therapeutic gap with a minimally invasive, image-guided therapy for contained herniated discs, called Triojection® a not yet approved therapy, which consists in delivering an ozone-oxygen mixture into the disc. Preliminary data from studies indicates the potential of this outpatient procedure to address disc volume and related nerve pressure, pending further clinical validation and regulatory approval.
FinSMEs
19/12/2024